Carregant...

A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.

The application of DNA technology to regulate the transcription of disease-related genes in vivo has important therapeutic potentials. The transcription factor E2F plays a pivotal role in the coordinated transactivation of cell cycle-regulatory genes such as c-myc, cdc2, and the gene encoding prolif...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Morishita, R, Gibbons, G H, Horiuchi, M, Ellison, K E, Nakama, M, Zhang, L, Kaneda, Y, Ogihara, T, Dzau, V J
Format: Artigo
Idioma:Inglês
Publicat: 1995
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC41600/
https://ncbi.nlm.nih.gov/pubmed/7597041
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!